Medtronic has launched a clinical trial to assess the safety and efficacy of adaptive deep brain stimulation, or aDBS, an investigational feature of its Percept PC Neurostimulator device, in people with Parkinson’s disease. Unlike conventional continuous deep brain stimulation, known as cDBS — in which electrical signals used for brain stimulation must be manually adjusted to suit the needs of each patient — aDBS allows these signals to be automatically adjusted to ease patients’ symptoms,…

You must be logged in to read/download the full post.